Uterine adenocarcinoma is a malignant tumor that originates from the glandular cells of the inner layer of the uterus. It most commonly develops in women aged 50 and older, although it can sometimes occur in younger women. Uterine adenocarcinoma is among the most common types of cancer affecting female reproductive organs.
Uterine adenocarcinoma is classified based on the extent of tumor spread. Stages I-IV are distinguished, where stage I means the tumor is confined to the uterus, and stage IV means the tumor has spread beyond the pelvis.
The exact causes of uterine adenocarcinoma are not fully established, but hormonal changes, obesity, genetics, and other factors are believed to play a role.
Various methods, including ultrasound, magnetic resonance imaging, biopsy, and others, are used for diagnosing uterine adenocarcinoma.
Treatment for uterine adenocarcinoma may include surgical intervention, radiation therapy, and chemotherapy.
Prevention of uterine adenocarcinoma involves regular gynecological examinations, maintaining a healthy lifestyle, and weight control.
For diagnosis and treatment of uterine adenocarcinoma, it is necessary to consult a gynecologic oncologist.
Note: This material is provided for informational purposes only and is not medical advice.